- Treating pancreatic tumours may have revealed cancer’s master switch The Economist
- Breakthrough pancreatic cancer drug nearly doubles survival in trial USA Today
- Georgia hospitals test ‘game-changer’ pancreatic cancer drugs Atlanta Journal-Constitution
- Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD Yahoo Finance
- A New Targeted Option on the Horizon for Pancreatic Cancer – CancerWorld Oncodaily
Add Comment